MITF reprograms the extracellular matrix and focal adhesion in melanoma

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Biology

Background:

• The microphthalmia-associated transcription factor (MITF) is crucial for melanocyte development and differentiation.
• MITF functions as a molecular rheostat in melanoma, enabling reversible switching between cellular states.
• Understanding MITF's regulatory roles is key to deciphering melanoma progression and therapeutic resistance.

Purpose of the Study:

• To investigate the direct transcriptional targets of MITF in human melanoma cells.
• To elucidate MITF's role in regulating genes involved in extracellular matrix (ECM) and focal adhesion pathways.
• To determine if MITF's effects on gene expression and cellular phenotype are reversible.

Main Methods:

• Gene expression analysis in human melanoma cells with varying MITF activity.
• Assessment of cell morphology and cell-matrix interactions.
• Evaluation of focal adhesion dynamics and epithelial-to-mesenchymal transition (EMT) markers.

Main Results:

• MITF directly represses genes in ECM and focal adhesion pathways, including EMT regulators like CDH2.
• MITF repression affects melanoma cell morphology and cell-matrix interactions.
• These MITF-mediated effects are reversible, consistent with the molecular rheostat model.
• MITF knockdown leads to increased focal adhesion points, a characteristic of drug-resistant melanomas.
• MITF-deficient cells resemble minimal residual disease cells in human and zebrafish melanomas.

Conclusions:

• MITF acts as a critical transcriptional repressor in melanoma.
• MITF actively shapes the melanoma cell microenvironment in a cell-autonomous manner.
• MITF's regulatory functions are integral to melanoma cell plasticity, progression, and potential drug resistance mechanisms.